Inter Pharma Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Inter Pharma has been growing earnings at an average annual rate of 10.9%, while the Personal Products industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 36.6% per year. Inter Pharma's return on equity is 1%, and it has net margins of 1.1%.
Anahtar bilgiler
10.9%
Kazanç büyüme oranı
2.9%
EPS büyüme oranı
Personal Products Sektör Büyümesi | 3.7% |
Gelir büyüme oranı | 36.6% |
Özkaynak getirisi | 1.0% |
Net Marj | 1.1% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Inter Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 1,809 | 20 | 607 | 0 |
31 Mar 24 | 1,809 | 27 | 597 | 0 |
31 Dec 23 | 1,799 | 51 | 568 | 0 |
30 Sep 23 | 1,815 | 92 | 555 | 0 |
30 Jun 23 | 1,775 | 108 | 540 | 0 |
31 Mar 23 | 1,739 | 128 | 513 | 0 |
31 Dec 22 | 1,534 | 119 | 458 | 0 |
30 Sep 22 | 1,385 | 130 | 390 | 0 |
30 Jun 22 | 1,226 | 125 | 339 | 0 |
31 Mar 22 | 1,016 | 118 | 284 | 0 |
31 Dec 21 | 921 | 105 | 267 | 0 |
30 Sep 21 | 760 | 68 | 253 | 0 |
30 Jun 21 | 626 | 63 | 230 | 0 |
31 Mar 21 | 526 | 56 | 202 | 0 |
31 Dec 20 | 447 | 53 | 187 | 0 |
30 Sep 20 | 408 | 62 | 162 | 0 |
30 Jun 20 | 390 | 57 | 155 | 0 |
31 Mar 20 | 389 | 56 | 156 | 0 |
31 Dec 19 | 376 | 43 | 157 | 0 |
30 Sep 19 | 371 | 28 | 175 | 0 |
30 Jun 19 | 365 | 27 | 176 | 0 |
31 Mar 19 | 343 | 24 | 169 | 0 |
31 Dec 18 | 318 | 30 | 152 | 0 |
31 Dec 17 | 248 | 16 | 120 | 0 |
31 Dec 16 | 125 | 16 | 59 | 0 |
Kaliteli Kazançlar: IP has high quality earnings.
Büyüyen Kar Marjı: IP's current net profit margins (1.1%) are lower than last year (6.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: IP's earnings have grown by 10.9% per year over the past 5 years.
Büyüme Hızlandırma: IP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: IP had negative earnings growth (-81.2%) over the past year, making it difficult to compare to the Personal Products industry average (-3.2%).
Özkaynak Getirisi
Yüksek ROE: IP's Return on Equity (1%) is considered low.